Literature DB >> 23440423

Regulation of lung cancer metastasis by Klf4-Numb-like signaling.

Valentina Vaira1, Alice Faversani, Nina M Martin, David S Garlick, Stefano Ferrero, Mario Nosotti, Joseph L Kissil, Silvano Bosari, Dario C Altieri.   

Abstract

Metastatic traits seem to be acquired by transformed cells with progenitor-like cancer-initiating properties, but there remains little mechanistic insight into this linkage. In this report, we show that the polarity protein Numbl, which is expressed normally in neuronal progenitors, becomes overexpressed and mislocalized in cancer cells from a variety of human tumors. Numbl overexpression relies on loss of the tumor suppressor miRNA-296-5p (miR-296), which actively represses translation of Numbl in normal cells. In turn, deregulated expression of Numbl mediates random tumor cell migration and invasion, blocking anoikis and promoting metastatic dissemination. In clinical specimens of non-small cell lung cancer, we found that Numbl overexpression correlated with a reduction in overall patient survival. Mechanistically, Numbl-mediated tumorigenesis involved suppression of a "stemness" transcriptional program driven by the stem cell programming transcription factor Klf4, thereby preserving a pool of progenitor-like cells in lung cancer. Our results reveal that Numbl-Klf4 signaling is critical to maintain multiple nodes of metastatic progression, including persistence of cancer-initiating cells, rationalizing its therapeutic exploitation to improve the treatment of advanced lung cancer. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23440423      PMCID: PMC3695627          DOI: 10.1158/0008-5472.CAN-12-4232

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Epithelial cell polarity, stem cells and cancer.

Authors:  Fernando Martin-Belmonte; Mirna Perez-Moreno
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

2.  The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

Authors:  Michelangelo Cordenonsi; Francesca Zanconato; Luca Azzolin; Mattia Forcato; Antonio Rosato; Chiara Frasson; Masafumi Inui; Marco Montagner; Anna R Parenti; Alessandro Poletti; Maria Grazia Daidone; Sirio Dupont; Giuseppe Basso; Silvio Bicciato; Stefano Piccolo
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 3.  The developing cancer stem-cell model: clinical challenges and opportunities.

Authors:  Louis Vermeulen; Felipe de Sousa e Melo; Dick J Richel; Jan Paul Medema
Journal:  Lancet Oncol       Date:  2012-02       Impact factor: 41.316

Review 4.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 5.  Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

6.  Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.

Authors:  Jian-Jun Wei; Xinyu Wu; Yi Peng; Guizhi Shi; Olca Basturk; Basturk Olca; Ximing Yang; Garrett Daniels; Iman Osman; Jiangyong Ouyang; Eva Hernando; Angel Pellicer; Johng S Rhim; Jonathan Melamed; Peng Lee
Journal:  Clin Cancer Res       Date:  2010-12-07       Impact factor: 12.531

7.  Aberrant overexpression of the cell polarity module scribble in human cancer.

Authors:  Valentina Vaira; Alice Faversani; Takehiko Dohi; Marco Maggioni; Mario Nosotti; Delfina Tosi; Dario C Altieri; Silvano Bosari
Journal:  Am J Pathol       Date:  2011-05-06       Impact factor: 4.307

Review 8.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

9.  miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.

Authors:  V Vaira; A Faversani; T Dohi; M Montorsi; C Augello; S Gatti; G Coggi; D C Altieri; S Bosari
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

10.  Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity.

Authors:  Shailaja Akunuru; Joseph Palumbo; Qihui James Zhai; Yi Zheng
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

View more
  30 in total

Review 1.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 2.  MicroRNAs: master regulators of drug resistance, stemness, and metastasis.

Authors:  Umar Raza; Jitao David Zhang; Ozgür Sahin
Journal:  J Mol Med (Berl)       Date:  2014-02-09       Impact factor: 4.599

Review 3.  Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.

Authors:  Mingjing He; Zhuan Zhou; George Wu; Qianming Chen; Yong Wan
Journal:  Pharmacol Ther       Date:  2017-03-06       Impact factor: 12.310

Review 4.  Role of Krüppel-like factors in cancer stem cells.

Authors:  Yueling Zhang; Jin Hao; Yingcheng Zheng; Dian Jing; Yu Shen; Jun Wang; Zhihe Zhao
Journal:  J Physiol Biochem       Date:  2015-01-24       Impact factor: 4.158

Review 5.  Current status in cancer cell reprogramming and its clinical implications.

Authors:  Kenan Izgi; Halit Canatan; Banu Iskender
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

6.  KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis.

Authors:  Yongmin Yan; Zhiwei Li; Xiangyu Kong; Zhiliang Jia; Xiangsheng Zuo; Mihai Gagea; Suyun Huang; Daoyan Wei; Keping Xie
Journal:  Cancer Res       Date:  2016-02-15       Impact factor: 12.701

7.  Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion.

Authors:  Evan J Greenawalt; Mick D Edmonds; Neha Jain; Clare M Adams; Ramkrishna Mitra; Christine M Eischen
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

Review 8.  Pluripotency transcription factors in lung cancer-a review.

Authors:  Sylwia Sławek; Krzysztof Szmyt; Maciej Fularz; Joanna Dziudzia; Maciej Boruczkowski; Jan Sikora; Mariusz Kaczmarek
Journal:  Tumour Biol       Date:  2015-11-18

9.  Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.

Authors:  Maogui Hu; Xinchen Wang; Ning Liu; Kaiyang Ding; Guihong Zhang; Xiaosi Liu
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

10.  A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.

Authors:  Anu Loukola; Jadwiga Buchwald; Richa Gupta; Teemu Palviainen; Jenni Hällfors; Emmi Tikkanen; Tellervo Korhonen; Miina Ollikainen; Antti-Pekka Sarin; Samuli Ripatti; Terho Lehtimäki; Olli Raitakari; Veikko Salomaa; Richard J Rose; Rachel F Tyndale; Jaakko Kaprio
Journal:  PLoS Genet       Date:  2015-09-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.